4-Methylumbelliferone (4-MU)

Catalog No.S2256

4-Methylumbelliferone (4-MU) Chemical Structure

Molecular Weight(MW): 176.17

4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.

Size Price Stock Quantity  
In DMSO USD 90 In stock
USD 70 In stock
USD 210 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Biological Activity

Description 4-Methylumbelliferone is a hyaluronic acid (HA) synthesis inhibitor with an IC50 of 0.4 mM.
Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
COS1 cells M4nIOWZ2dmO2aX;uJIF{e2G7 NHjwbmVC\2:waYP0bYMh[WO2aY\peJkhf2G|IHTleIVzdWmwZXSgbY4hS0:VMTDj[YxteyC2cnHud4Zm[3SnZDD3bZRpKEeDTDC0MXBRSVJiZ3HtcYEhemWlZYD0c5ItKEWFNUC9NE4xOjFizszN M1PPNVEzPjF5OUK0
CV-1 cells MmHoSpVv[3Srb36gZZN{[Xl? NEjQSJhO[XirbXHsJJJmeG:{dHXyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iUHXyc5hqe2:vZTDwdo9tcW[ncnH0c5Ih[WO2aY\heIVlKHKnY3XweI9zKGejbX3hJGdidDRiY3jpcYVzcWNiaX6geJJidnOrZX70cJkhfHKjboPm[YN1\WRiQ2[tNUBk\WyuczDifUBnfW6ldHnvcoFtKGG|c3H5MEBGSzVyPUCuNFQ{KM7:TR?= NXXSNoVpOTF5MkC4OVQ>
COS-1 cells M3Hte2Z2dmO2aX;uJIF{e2G7 NHrVeGtKdiC4aYTyc{B1emGwc3HjeIl3[XSrb36gc4YhcHWvYX6gdIVzd3irc3;t[UBxem:uaX\ldoF1d3JiYXP0bZZifGWmIILlZ4VxfG:{IHfhcY1iKG2nYYP1doVlKGmwIGDQRXIuT0GONDDjbIlu\XKrYzDDU3MuOSClZXzsd{whTUN3ME2wMlAzKM7:TR?= NYjWcmZPOTJ6N{O1NVc>
CV-1 cells NXnQR|EyTnWwY4Tpc44h[XO|YYm= MYDBZ5RqfmG2aX;uJI9nKHCncn;4bZNwdWVicILvcIln\XKjdH;yJIFkfGm4YYTl[EBz\WOncITvdkBo[W2vYTDt[YF{fXKnZDDifUBqdmS3Y4Tpc44hd2ZiNUClJI9nKG2jeHnteY0h[WytYXzpcoUheGixc4DoZZRie2ViYXP0bZZqfHluIITyZY5{\mWldHnvckBie3OjeTDpckBEXi1zIHPlcIx{NCCHQ{WwQVAvODh7MUOg{txO M{GzZlk5OzZ4MkC=
CV-1 cells M3;DSmZ2dmO2aX;uJIF{e2G7 MVXJckB3cXS{bzD0doFve2O{aYD0bY9v[WxiYXP0bZZifGmxbjDv[kBR\XKxeHnzc41mKHC{b3zp[oVz[XSxcjDhZ5RqfmG2ZXSgdoVk\XC2b4Kg[4FudWFiKGDQRXIqKGW6cILld5Nm\CCrbjDDWk0yKGOnbHzzMEBGSzVyPUCuNFYh|ryP NF\GVW05PTd4OUC3
COS-1 cells NEXlV5VHfW6ldHnvckBie3OjeR?= MoOwTY4hfmm2cn:gZYdwdmm|dDDhZ5Rqfmm2eTD0[ZN1\WRiZn;yJJRz[W6|YXP0bZZifGmxbjDpckBpfW2jbjDQVGFTKGejbX3hMWdidDRiY3jpcYVzcWNiQ1;TMVEh[2WubIOsJGVEPTB;MD6wNkDPxE1? M4XNbVEzPzJ7Nk[4
CV-1 cells MXfGeY5kfGmxbjDhd5NigQ>? MkmzTY4hfmm2cn:g[ZZidHWjdHnvckBi\2GrboP0JHJZWi2jbIDoZU9RWEGULXfhcY1iKGmwIFPWMVEh[2WubIOgZpkh[2:2cnHud4Zm[3Srb36gZZN{[Xlid3HzJIRmfGW{bXnu[YQtKEWFNUC9NE4{OjVizszN M4XCS|EzQTV2ME[x
HepG2 cells NWLsO|R2TnWwY4Tpc44h[XO|YYm= MVnF[oZm[3SrdnWgZ49v[2WwdILheIlwdiCjZ3HpcpN1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iSHXwS|Ih[2WubIOsJGVEPTB;MD6wN|kh|ryP NWr1UG5KOTZzMEexOVA>
Huh7 cells NWH3fmlJTnWwY4Tpc44h[XO|YYm= MlvFSpVv[3Srb37hcEBi[3Srdnn0fUBifCCqdX3hckBRWEGUIHfhcY1iKGmwIFj1bFch[2WubIOgZpkhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMkKg{txO MoLuNVY{PjZ4MEG=
Huh7 cells MUDGeY5kfGmxbjDhd5NigQ>? M1TWXWVn\mWldDDvckBRWEGUIHfhcY1iKHS{YX7zZYN1cX[jdHnvckBi[3Srdnn0fUBqdiCKdXi3JINmdGy|LDDFR|UxRTBwMkKg{txO MVKxOlQ2OTB6Nx?=
U2OS cells M2fLWWZ2dmO2aX;uJIF{e2G7 MVPF[oZm[3Rib36gVHBCWmejbX3hJJRz[W6|YXP0bZZifGmxbjDhZ5Rqfmm2eTDpckBWOk:VIHPlcIx{NCCHQ{WwQVAvODNizszN NWDXZ2syOTZ|MEC5OFQ>
CV1 cells M4jlVmZ2dmO2aX;uJIF{e2G7 NHXoTHhVemGwc3HjeIl3[XSrb36gc4YhWFCDUnfhcY1iKGmwIFPWNUBk\WyuczygSWM2OD1yLkC3OkDPxE1? MkPENVY5OjF5Nkm=
human keratinocytes M2q2b3Bzd2yrZnXyZZRqd25iYYPzZZk> NGP2PXdCdnSrcILvcIln\XKjdHn2[UBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIHvldoF1cW6xY4n0[ZMtKEWFNUC9PEDPxE1? M1HsWlE3QDJzN{[5
HT29 cell M1fhfnBzd2yrZnXyZZRqd25iYYPzZZk> M4mwXWFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSGSyPUBk\WyuIHzpcoUtKEWFNUC9OFUh|ryP NEPhXYcyPjh{MUe2PS=>
NIH3T3 cells MX3GeY5kfGmxbjDhd5NigQ>? NYfNUIVnSWO2aY\peJkh[XRiaIXtZY4hWFCDUjDnZY1u[SC2cnHud4Zm[3SnZDDpckBPUUh|VEOgZ4VtdHNiYomgcJVkcW[ncnHz[UBi[3Srdnn0fUBie3OjeTygSWM2OD1yLkOyJO69VQ>? M{HpR|E3QDV2MEi1
CV1 cells NYXsVm1uTnWwY4Tpc44h[XO|YYm= MnjzWJJidnOjY4TpeoF1cW:wIH;mJIh2dWGwIGDQRXJo[W2vYTDpckBEXjFiY3XscJMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuN|A5KM7:TR?= NFHHZVUyPjl5MEO5NS=>
Huh7 cells MU\GeY5kfGmxbjDhd5NigQ>? M4rwc2FkfGm4aYT5JIF1KGi3bXHuJHBRSVJiZ3HtcYEhcW5iSIXoO{Bk\WyuczDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5{MjFOwG0> NEH0XIQyPzB|NEG0PS=>
HepG2 cells Mn7oSpVv[3Srb36gZZN{[Xl? MoLzRYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFTKGejbX3hJIlvKGFiSHXwS|Ih[2WubIOgZpkhWFCDUj3HRWw1KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkG1PEDPxE1? M3\lTlE3QTd|M{W4
HepG2 cells MXzGeY5kfGmxbjDhd5NigQ>? M1vFUWFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWiCpYX3tZUBqdiCKZYDHNkBk\WyuczDifUBRWEGULVfBUFQhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMUW4{txO M4XXNFE3QTd7M{Sx
CV1 cells M{jDNGZ2dmO2aX;uJIF{e2G7 M3fDTWFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBqdiCFVkGgZ4VtdHNuIFXDOVA:OC5|MEig{txO MXqxO|AxPTN7NB?=
HEK293 cells M{\OU2Z2dmO2aX;uJIF{e2G7 NUTnbVNxSWO2aY\peJkh[XRiaIXtZY4h[WSrcH;z[UB1cXO|dXWgVHBCWiCpYX3tZUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIJ6KFCSQWKtS2FNPCC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6zNUDPxE1? MXWxO|M1OzN5MR?=
rat L6 cells NELXb5JHfW6ldHnvckBie3OjeR?= MXPF[oZm[3Rib36g[oF1fHliYXPp[EBwgGmmYYTpc44hcW5icnH0JGw3KGOnbHzzMEBGSzVyPUWg{txO M4rXNFE4OzR|M{ex
HepG2 cells MVzGeY5kfGmxbjDhd5NigQ>? M2DmW2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIlvKEincFeyJINmdGy|IHL5JHBRSVJvR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yOEKg{txO MV:xO|E2PzBzOR?=
CV1 cells M1LZXGZ2dmO2aX;uJIF{e2G7 NYni[W9{SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUYXzwbIEhcW5iQ2[xJINmdGy|IHL5JGdCVDRidILhcpNi[3SrdnH0bY9vKGG|c3H5JIFnfGW{IEK0JIhzeyxiRVO1NF0{NjR4IN88US=> NFzFXYUyPzVyN{KyOS=>
CV1 cells NFHWPVFHfW6ldHnvckBie3OjeR?= M{jxWmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIlvKEOYMTDj[YxteyCkeTDHRWw1KHS{YX7zZYN1cX[jdHnvckBie3OjeTDh[pRmeiB{NDDodpMtKEWFNUC9NE4xOyEQvF2= NFmzeIwyPzVyN{KyOS=>
CV1 cells NW\sZYZvTnWwY4Tpc44h[XO|YYm= NFHTN|lC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iQ2[xJINmdGy|IHL5JJJm[2WydH;yJJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjNyODFOwG0> Mn:zNVgxOjlzN{i=
CV1 cells NFrHXHJHfW6ldHnvckBie3OjeR?= MoPlRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5iQ2[xJINmdGy|IHL5JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjNyODFOwG0> M{fpdVE4OTJ7N{K1
HEK293 cells Ml;GSpVv[3Srb36gZZN{[Xl? MVPB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBz\WOncITvdkBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIJ6KEeDTESgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODN3IN88US=> M13jZVE4Ojl{NkC2
NIH3T3 cells NGfLO|BHfW6ldHnvckBie3OjeR?= NYT6bYhjSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIF7JTFNVOyClZXzsd{BjgSCJQVy0JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjN{IN88US=> MXexO|YzPDd5Nx?=
HEK293 cells NYnQNWVyTnWwY4Tpc44h[XO|YYm= NX63R|J6SWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCkeTDHRWw1KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkG5JO69VQ>? MVexPFAzQTF5Nh?=
HEK293 cells M2n3ZmZ2dmO2aX;uJIF{e2G7 NVfnXXJlSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJGhGUzJ7MzDj[YxteyCjc4Pld5Nm\CCjczDhVFIh\2WwZTDpcoR2[3Srb36sJGVEPTB;MD6xNkDPxE1? M{PtclE5ODJ7MUe2
HEK293 cells M1zGNmZ2dmO2aX;uJIF{e2G7 NHraR2xC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCrbjDISWszQTNiY3XscJMh[nliR1HMOEB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yNEWg{txO NF\FUIMyQDJ7MU[0OS=>
HepG2 cells M4DyeWZ2dmO2aX;uJIF{e2G7 M3jjNmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmGucHjhJIxq\2GwZDDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gbJVu[W5iSHXwS|Ih[2WubIOgZ48ufHKjboPm[YN1\WRid3n0bEBI[Wx2IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjB|OTFOwG0> NXTzbZhSOTh6M{W3NVk>
RAW264.7 cells NYfKNXRuTnWwY4Tpc44h[XO|YYm= M4jD[XN2eHC{ZYPzbY9vKG:oIFzQV{9KTk5vZ3HtcYEue3SrbYXsZZRm\CCQTzDwdo9lfWO2aX;uJIlvKG2xdYPlJHJCXzJ4ND63JINmdGy|LDDFR|UxRTF5LkWg{txO M1\MSlE5QDB7M{K1
BL21 cells NXLYRnNQTnWwY4Tpc44h[XO|YYm= MV;EbZNxdGGlZX3lcpQhd2ZicnHkbY8hdGGkZXzl[EAzMFNrLTiyMYJmdnqxeXytdIhmdnmuYX3pco8qNTNve{StX|EtOS2maYTybZRqdy1{LTi1MY1mfGi7bD2yMZBp\W67bD3vfIF7d2xvND35cEku\XSqb4j5YU1xcGWweXz9MZBzd3Crb37pZ{Bi[2mmIH\yc40hT1OWLX\1d4VlKGi3bXHuJHBRSVKpYX3tZUBmgHC{ZYPz[YQhcW5iRYPjbIVzcWOqaXGgZ49tcSCETEKxJINmdGy|IHL5JJNkcW62aXzsZZRqd25icILvfIlucXS7IHHzd4F6NCCHQ{WwQVAvPDVizszN MWmxPVM1QTF5Nh?=
BHK21 cells MXLGeY5kfGmxbjDhd5NigQ>? NYPJU|J3SWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFLIT|IyKGOnbHzzJIF{e2W|c3XkJIF{KFOHQWCgZYN1cX[rdImgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD60OUDPxE1? NHXN[GEyQTN2OUG3Oi=>
HepG2/C3A cells M3q5W2Z2dmO2aX;uJIF{e2G7 Mn;iRYN1cX[jdHnvckBw\iCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwLX3l[IlifGWmIITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCrbjDoeY1idiCKZYDHNk9EO0FiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCodYPl[EBI[Wx2LVzCSEBjgSClb4TyZY5{\mWldHnvckBie3OjeTygSWM2OD1yLkCwN|gh|ryP NGD5XnAyPzRyM{[4PC=>
HepG2 cells MljjSpVv[3Srb36gZZN{[Xl? NFr4N21C\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCneIDy[ZN{\WRiaX6gbJVu[W5iSHXwS|Ih[2WubIOgZZN{\XO|ZXSgZZMhcW6mdXP0bY9vKG:oIILlZ4VxfG:{IITyZY5{[WO2aY\heIlwdiCkeTDy[ZBwenSncjDn[Y5mKGG|c3H5JJJmdGG2aY\lJJRwKGOxboTyc4wtKEWFNUC9NE4xPSEQvF2= M2OzWVE5PjJ3NUW5
COS1 cells MV3GeY5kfGmxbjDhd5NigQ>? NXTVXmFVSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBz\WOxbXLpcoFvfCCSUFHS[4FudWFiZYjwdoV{e2WmIHnuJGNQWzFiY3XscJMh[29vZYjwdoV{e2mwZzDHRWw1KGG|c3Xzd4VlKGG|IITyZY5{[3KrcITpc45idCCjY4Tpeol1gSCjZoTldkA1QCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEKg{txO NVvo[3VVOTl3MEe4OlE>
HepG2 cells MU\GeY5kfGmxbjDhd5NigQ>? MUPB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hUGWyR{KgZ4VtdHNiYomgS2FNPCC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6yNlMh|ryP MmTKNVg{QTR7MEe=
CV1 cells M4DYOWZ2dmO2aX;uJIF{e2G7 MUPB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDsbYdidmRiYnnu[Ilv\yCmb33hbY4h\XiycnXzd4VlKGmwIHHmdolk[W5iZ4Ll[Y4hdW:wa3X5JGNXOSClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKG[3c3XkJGdidDRvRFLEJIJ6KHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkCzN{DPxE1? MX:xPFgzPjJyNR?=
CV1 cells M3exUWZ2dmO2aX;uJIF{e2G7 NWn6cGszSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUYXzwbIEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBi\nKrY3HuJIdz\WWwIH3vcotmgSCFVkGgZ4VtdHNiY3:teJJidnOoZXP0[YQhf2m2aDDmeZNm\CCJYXy0MWRDTCCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9N{41PiEQvF2= M1O0OlE5QDJ4MkC1
U2OS cells M4j3OWZ2dmO2aX;uJIF{e2G7 MnK4RYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGgbY4hXTKRUzDj[YxteyCkeTD0doFve2GldHn2ZZRqd25iYYPzZZktKEWFNUC9NE4xOiEQvF2= Mn;WNVg{Ojl5NUG=
Hep G2 cells MmPPSpVv[3Srb36gZZN{[Xl? NETEWWFC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJIh2dWGwIFjldEBIOiClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKEejbEStSGJFKGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlA1KM7:TR?= NE\ESpMyQTB3M{e3Oi=>
HeLa cells NF63fmJHfW6ldHnvckBie3OjeR?= MYXB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJIh2dWGwIFjlUIEh[2WubIOgZ48ufHKjboPm[YN1\WRid3n0bEBI[Wx2LVTCSEBie3Onc4Pl[EBieyC2cnHud4NzcXC2aX;uZYwh[WO2aY\heIlwdiCkeTDHZYw1KHKnc4DvcpNmKGWuZX3lcpQu\HKrdnXuJIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjBzNTFOwG0> M4PiO|E6Ojd3OU[z
COS1 cells MUHGeY5kfGmxbjDhd5NigQ>? NVrxcHpYSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEhemWlZYD0c5Ih\XiycnXzd4VlKGmwIHHmdolk[W5iZ4Ll[Y4hdW:wa3X5JGNQWzFiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCodYPl[EB6\WG|dDDHZYw1NUSERDDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5yMjFOwG0> NX;KRXd3OTl3M{C2PFE>
U2OS cells MX\GeY5kfGmxbjDhd5NigQ>? NVzac|BRSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIGWyU3Mh[2WubIOgZpkhdHWlaX\ldoF{\SC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6wOUDPxE1? M2LHeVE6PTd2MEW2
HepG2 cells MlrhSpVv[3Srb36gZZN{[Xl? M13nd2Fod26rc4SgZYN1cX[rdImgZZQhT0GOND30ZYdo\WRiaIXtZY4hWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVxTzJiY3XscJMh[XO|ZYPz[YQh[XNicnXj[ZB1d3JidILhcpNi[3SrdnH0bY9vKGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlA{QSEQvF2= MX[xPVc4PTF4OR?=
HepG2 cells M4LiUGZ2dmO2aX;uJIF{e2G7 M1f3[WFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCKZYDHNkBk\WyuczDifUBISUx2IITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlIzOyEQvF2= NUDmXHNQOTl5OEO0OFQ>
COS7 cells M1rFZWZ2dmO2aX;uJIF{e2G7 NETDc4JC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJJJm[2:vYnnuZY51KFCSQWLnZY1u[TJiTFLEJIV5eHKnc4Pl[EBqdiCjZoLpZ4FvKGe{ZXXuJI1wdmuneTDDU3M4KGOnbHzzJINw\XiycnXzd4lv\yCJQVy0JIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5zIN88US=> MmfvNlAyOzh5NkK=
COS7 cells MX\GeY5kfGmxbjDhd5NigQ>? M1jrXmFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gdoVkd22kaX7hcpQhWFCDUnfhcY1iOSCOQlSg[ZhxemW|c3XkJIlvKGGocnnjZY4h\3KnZX6gcY9vc2W7IFPPV|ch[2WubIOgZ49mgHC{ZYPzbY5oKEeDTESgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjB|IN88US=> MXKyNFE{QDd4Mh?=
HEK cells MoXJSpVv[3Srb36gZZN{[Xl? NUi4bWROSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBISUx2LYTh[4dm\CCSUFHSZYxxcGFiY3jpcYVzcWNicnXj[ZB1d3JiZYjwdoV{e2WmIHnuJGhGUyClZXzsd{BjgSC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MUCuOVgh|ryP MYSyNFI6QTJzNB?=
HEK cells M{LmOGZ2dmO2aX;uJIF{e2G7 MWLB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIFfBUFQufGGpZ3XkJHBRSVKpYX3tZUBkcGmvZYLpZ{Bz\WOncITvdkBmgHC{ZYPz[YQhcW5iSFXLJINmdGy|IHL5JJRz[W6|YXP0bZZifGmxbjDhd5NigSxiRVO1NF0xNjB|NTFOwG0> NYDqZZlPOjB{OUmyNVQ>
3T3L1 cells NUn1ZWkxTnWwY4Tpc44h[XO|YYm= NWPtdWxCPyCmYYnz NF6wcmdKdmS3Y4Tpc44hd2ZiYXTpdI9o\W6nc3nzJIlvKG2xdYPlJFNVO0xzIHPlcIx{KGG|c3Xzd4VlKGG|IHnuZ5Jm[XOnIHnuJIxqeGmmIHHjZ5VufWyjdHnvckBi\nSncjC3JIRigXNiYomgU4ltKHKnZDDPJJN1[WmwaX7n Moi2NlA2Ojd7Nkm=
CHO-K1 cells Ml7GSpVv[3Srb36gZZN{[Xl? NVHmcohMWGG{dHnhcEBi\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZU1NSkRiZYjwdoV{e2WmIHnuJGNJVy2NMTDj[YxteyClbz30doFve2[nY4Tl[EB4cXSqIFfBUFQh[XO|ZYPz[YQh[XNibIXjbYZmemG|ZTDhZ5Rqfmm2eTDifUB1emGwc3HjeIl3[XSrb36gZZN{[XluIFXDOVA:OC5zIN88US=> MUiyNFUzPzl4OR?=
HEK293T cells NIWwTGZHfW6ldHnvckBie3OjeR?= M3rRU|Eh|ryP NYnOeWhMOjRiaILz NGr0ZWdR[XK2aXHsJIFod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hMWxDTCCneIDy[ZN{\WRiaX6gTGVMOjl|VDDj[YxteyCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhemWlZYD0c5IhfHKjboPhZ5RqfmG2aX;uJIF1KDFidV2gZYZ1\XJiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> NGS5WFYzOTB|MEK2Ny=>
CV1 cells NF65N4pHfW6ldHnvckBie3OjeR?= NYD4R4poXHKjboPhZ5RqfmG2aX;uJI9nKEejbESt[pV{\WRiaIXtZY4hWFCDUnfhcY1iKESQQTDibY5lcW6pIHTvcYFqdiCneIDy[ZN{\WRiaX6gZYZzcWOjbjDndoVmdiCvb37r[ZkhS1ZzIHPlcIx{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfUwhTUN3ME2wMlEh|ryP M{\TTlIyOTF{N{i0
HEK293 cells NY\4cHhzTnWwY4Tpc44h[XO|YYm= NXPKd3hEOTZidH:gNlAhcHK| Ml36WJJidnOjY4TpeoF1cW:wIH;mJGdidDRvZoXz[YQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZYZ1\XJiMU[geI8hOjBiaILzJIJ6KGy3Y3nm[ZJie2VicnXwc5J1\XJiZ3Xu[UBie3OjeTygSWM2OD1yLkC0N{DPxE1? M4PMT|IyOTJ6NkCw
HepG2 cells M{PyVGZ2dmO2aX;uJIF{e2G7 M3\aO|ExKHWvb3yvUC=> MlPiNlQhcHK| MYDJcoNz\WG|ZTDpckBodHWlb4PlJINwdnO3bYD0bY9vKGmwIHj1cYFvKEincFeyJINmdGy|IHH0JFExKHWvb3yvUEBi\nSncjCyOEBpenNicnXsZZRqfmVidH:gZ49vfHKxbB?= NXq4e4dGOjF{NU[3OFg>
3T3L1 cell M{fERmZ2dmO2aX;uJIF{e2G7 NH3NemMyKHWP MV3JcoR2[3Srb36gc4YhdW:3c3WgN3Q{VDFiY3XscEBlcW[oZYLlcpRq[XSrb36gZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iYXPjeY12dGG2aX;uJI9nKGmwdILhZ4VtdHWuYYKgcIlxcWRiZILvdIxmfCCjdDCxJJVOKGK7IF;pcEBz\WRiTzDzeIFqdmmwZx?= M1jub|IyPDBzMUG4
CV1 cells MWPGeY5kfGmxbjDhd5NigQ>? M1\0ZVQxKGh? NHzUZXFC\2:waYP0JIFkfGm4aYT5JIF1KGi3bXHuJHBRSVKpYX3tZU1NSkRiZYjwdoV{e2WmIHnuJGNXOSClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKEejbESgZYZ1\XJiNECgbJJ{KGK7IHz1Z4ln\XKjc3WgZoF{\WRidILhcpNi[3SrdnH0bY9vKGG|c3H5MEBGSzVyPUCuNUDPxE1? NUjJW2xkOjF3MUWwOlM>
HepG2 cells M1ruS2Z2dmO2aX;uJIF{e2G7 MULB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUBz\WOncITvdkBmgHC{ZYPz[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYomgVHBTTS2udXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6wNUDPxE1? NXnsZVNyOjF2OEK0OFY>
HepG2 cells MlzKSpVv[3Srb36gZZN{[Xl? MnyxWJJidnOjY4TpeoF1cW:wIH;mJIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVxTzJiY3XscJMh[29vdILhcpNn\WO2ZXSge4l1cCCSUGLFN{1VUy2OdXOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIF{e2G7LDDFR|UxRTBwMEWg{txO NF;GRoczOTR3MES2PC=>
COS7 cells MWjGeY5kfGmxbjDhd5NigQ>? MWXNc4R2dGG2aX;uJI9nKGi3bXHuJHBRSVKpYX3tZU1NSkRiZYjwdoV{e2WmIHnuJIFnemmlYX6g[5Jm\W5ibX;ub4V6KEORU{egZ4VtdHNiY3:teJJidnOoZXP0[YQhf2m2aDDHZYw1KGG|c3Xzd4VlKGG|IHHjeIl3[XSrb36gc4YhfHKjboPhZ5RqfmG2aX;uJIFkfGm4aYT5JIJ6KGy3Y3nm[ZJie2ViYYPzZZktKEWFNUC9NE4xPDNizszN MVGyNVg4OzB5MB?=
COS-1 cells NYDmXWZDTnWwY4Tpc44h[XO|YYm= MXuyOEBpenN? Mke0RYdwdmm|dDDhZ5Rqfmm2eTDheEBpfW2jbjDQVGFT\2GvbXGgcIlo[W6mIHLpcoRqdmdiZH;tZYlvKGW6cILld5Nm\CCrbjDDU3MuOSClZXzsd{Bi\nSncjCyOEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nLXLhd4VlKGy3bXnuc41mfHKrYzDhcoFtgXOrczygSWM2OD1yLkC0PEDPxE1? M3XIUFIzODVzMEW0
COS1 cells NGXDcmxHfW6ldHnvckBie3OjeR?= NXq4blR5OjRiaILz NUD3PGU2XHKjboPhZ5RqfmG2aX;uJI9nKGi3bXHuJIZ2dGxibHXu[5RpKFCSQWLnZY1u[SCneIDy[ZN{\WRiaX6gR29UOSClZXzsd{Bkdy22cnHud4Zm[3SnZDD3bZRpKFK[UnHsdIhiKGGodHXyJFI1KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5zMjFOwG0> NVvrV5BDOjJzOUezPVY>
MG-63 cells MV3GeY5kfGmxbjDhd5NigQ>? M{G1T2Fod26rc4SgZYN1cX[rdImgZZQhcHWvYX6gVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCPRz22N{Bk\WyuczDifUBz\XCxcoTldkBo\W6nLXLhd4VlKHS{YX7zZYN1cX[jdHnvckBie3OjeTygSWM2OD1yLkCxNUDPxE1? NGDN[2czOjJ{NU[0NS=>
COS1 cells MnS1SpVv[3Srb36gZZN{[Xl? MnLBRolv\GmwZzDh[oZqdmm2eTD0c{BpfW2jbjD3bYxlKHS7cHWgVHBCWmejbX3hJGxDTCCneIDy[ZN{\WRiaX6gR29UOSClZXzsd{Bkdy2neIDy[ZN{cW6pIFfBUFQh[nlic3PpcpRqdGyjdHnvckBxem:6aX3peJkh[XO|YYm= NULRZnhLOjJyN{C2NFQ>
MG-63 cells MYjGeY5kfGmxbjDhd5NigQ>? MUiyOEBpenN? NIfxNHBOd2S3bHH0bY9vKG:oIH\1cIwudGWwZ4ToJIh2dWGwIIDTS|Uu\nW|ZXSgVHBCWmejbX3hJIV5eHKnc4Pl[EBqdiCPRz22N{Bk\WyuczDjc{1mgHC{ZYPzbY5oKHCJVj3QNk1RWFKHIHHmeIVzKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[mG|ZXSgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODFzIN88US=> NFTDc5czOjd{N{S0PC=>
Ac2F cells MXTGeY5kfGmxbjDhd5NigQ>? M{jSWVAvOSC2bzCxNEDPxE1? Mn7zOkBpenN? MmLnRYdwdmm|dDDhZ5Rqfmm2eTDheEBRWEGUZ3HtcYEhcW5icnH0JGFkOkZiY3XscJMh[XO|ZYPz[YQh[XNibIXjbYZmemG|ZTDhZ5Rqfmm2eTDheEAxNjFidH:gNVAhfU1iYX\0[ZIhPiCqcoOgZpkhemWyb4L0[ZIh\2WwZTDhd5NigQ>? NUfjWVhmOjJ6MUmxPVA>
293H DA cells MmfrSpVv[3Srb36gZZN{[Xl? M{fmOFE3KGh? NH\UbYFC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCOQlSgbY4hcHWvYX6gNlk{UCCGQTDj[YxteyCjZoTldkAyPiCqcoOgZpkhXFJvRmLFWEBi[3SrdnH0bY9vKHKncH;yeIVzKGG|c3H5MEBGSzVyPUCuNFAzPCEQvF2= NH\ZO2UzOjV6Mkm3Ny=>
3T3L1 cells NYK4XWpDTnWwY4Tpc44h[XO|YYm= MnHTNVAhfU1? MUnJcoNz\WG|ZTDpckBi\Gmyb37lZ5RqdiCvUl7BJIxmfmWuczDpckBVVk[jbIDoZU1qdmS3Y3XkJI1wfXOnIEPUN2wyKGOnbHzzJJBz\XS{ZXH0[YQh[XRiMUCgeW0h[mWob4LlJHRPTi2jbIDoZUBkcGGubHXu[4UhemWuYYTpeoUhfG9iY3;ueJJwdA>? M3PSPFIyQDVzMEi5
HepG2 cells NFH1SYlHfW6ldHnvckBie3OjeR?= NHXSZ4oyOCC3TR?= M{DPdFI1KGh? NUnnZXVEWmWmdXP0bY9vKG:oIHfseYNwe2ViY3;ud5VueHSrb36gbY4hcW6|dXzpck1z\XOrc4ThcpQhcHWvYX6gTIVxTzJiY3XscJMh[XRiMUCgeW0h[W[2ZYKgNlQhcHK|IHL5JIdtfWOxc3Wgc5hq\GG|ZTDt[ZRpd2RiaX6gdJJme2WwY3Wgc4YhOjJwMjDtUUBw\iCpbIXjc5Nm NGDXTm4zOzB{NUK0OC=>
HepG2 cells NIfIeWNHfW6ldHnvckBie3OjeR?= NVTMSYZ{OTBidV2= M2fFUVI1KGh? M33DenJm\HWldHnvckBw\iCpbIXjc5NmKGOxboP1cZB1cW:wIHnuJIlve3WuaX6tdoV{cXO2YX70JIh2dWGwIFjldGczKGOnbHzzJIF1KDFyIIXNJIFnfGW{IEK0JIhzeyCkeTDncJVkd3OnIH;4bYRie2VibXX0bI9lKGmwIIDy[ZNmdmOnIH;mJFAvOSC3TTDv[kBqdnO3bHnu NIPaOHYzOzB{NUK0OC=>
THP1 cells M3KyOmZ2dmO2aX;uJIF{e2G7 M4rtWlExOCC3TR?= NI\veFQ{KGi{cx?= NGTZRVZVemGwc3HjeIl3[XSrb36gc4YhWFCDUnfhcY1iKGmwIHj1cYFvKFSKUEGgZ4VtdHNiYYPz[ZN{\WRiYYOg[IVkemWjc3WgbY4hVFCVLXnu[JVk\WRiTVPQNUBuWk6DIHX4dJJme3Orb36gZZQhOTByIIXNJJBz\WmwY4XiZZRm\CCob4KgN{BpenNicILpc5IhfG9iTGDTJINp[WyuZX7n[UBu\WG|dYLl[EBi\nSncjCxPEBpenNiYomgVnQuWEOUIHHuZYx6e2m|IILlcIF1cX[nIITvJJVvfHKnYYTl[EBkd262cn;s MUeyNlk{PDV|Nx?=
THP1 cells M4HJN2Z2dmO2aX;uJIF{e2G7 NFnhTW8yODBidV2= NVfWeZlIOyCqcoO= MlL3WJJidnOjY4TpeoF1cW:wIH;mJHBRSVKpYX3tZUBqdiCqdX3hckBVUFBzIHPlcIx{KGG|c3Xzd4VlKGG|IHTlZ5Jm[XOnIHnuJGxRWy2rbnT1Z4VlKEmONjDtVm5CKGW6cILld5Nqd25iYYSgNVAxKHWPIIDy[Ylv[3WkYYTl[EBnd3JiMzDodpMheHKrb4KgeI8hVFCVIHPoZYxt\W6pZTDt[YF{fXKnZDDh[pRmeiBzODDodpMh[nliUmStVGNTKGGwYXz5d4l{KHKnbHH0bZZmKHSxIIXueJJm[XSnZDDjc451em:u NVz2PZlFOjJ7M{S1N|c>
HepG2 cells NIHvTXJHfW6ldHnvckBie3OjeR?= M3\5dnRz[W6|YXP0bZZifGmxbjDv[kBISUx2LX\1d4VlKFCSQWLnZY1u[SCuaXfhcoQh[mmwZHnu[{Bld22jaX6geJJidnOoZXP0[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvOSEQvF2= NXXoUZp4OjJ7M{S1N|c>
HepG2 cells MVLGeY5kfGmxbjDhd5NigQ>? M3O2c|IxKGh? NWHHbYxpSWexbnnzeEBi[3Srdnn0fUBifCCqdX3hckBISUx2LX\1d4VlKFCSQWLnZY1u[SCuaXfhcoQh[mmwZHnu[{Bld22jaX6g[ZhxemW|c3XkJIlvKEincFeyJINmdGy|IHHmeIVzKDJyIHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTBwMEKg{txO NH35N2UzOjB6MUmzNi=>
BL21 DE3 cells M2GyXmZ2dmO2aX;uJIF{e2G7 NFPCc3JFcXOybHHj[Y1mdnRib3[gX|NJZXKxc3nncIl1[XqxbnWg[pJwdSCQLYTldo1qdmGuIFjpd{11[WepZXSgbJVu[W5iUGDBVodidW2jIHzp[4Fv\CCkaX7kbY5oKGSxbXHpckBmgHC{ZYPz[YQhcW5iRYPjbIVzcWOqaXGgZ49tcSCETEKxJGRGOyClZXzsd{BjgSC|Y3nueIltdGG2aX;uJJBzd3irbXn0fUBie3OjeTygT4k:OC5yN{Sg{txO NGTpXlEzOjB6MUmzNi=>
human L02 cells Ml7GSpVv[3Srb36gZZN{[Xl? NXjK[I5kSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFvTFLEJIV5eHKnc4Pl[EBqdiCqdX3hckBNODJiY3XscJMh[29vZYjwdoV{e2mwZzDwS2w{NVOYNECtS2FNPCCjZoTldkAzPCCqcoOgZpkhdHWlaX\ldoF{\SC{ZYDvdpRmeiCpZX7lJIJie2WmIITyZY5{[WO2aY\heIlwdiCjc4PhfUwhTUN3ME2wMlkh|ryP M1zEb|I{OTh4M{C3
HepG2 cells NGTTdoRHfW6ldHnvckBie3OjeR?= NWTWU21ZOjBiaB?= M13HUXRz[W6|YXP0bZZifGmxbjDv[kBISUx2LX\1d4VlKGi3bXHuJHBRSVKpYX3tZUBtcWejbnSgZolv\GmwZzDkc41icW5iZYjwdoV{e2WmIHnuJGhmeEd{IHPlcIx{KGGodHXyJFIxKGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5yM{mg{txO NX\mZYw4OjNzN{GwOFU>
HEK293 cells M3fKS2Z2dmO2aX;uJIF{e2G7 MYGxNEDPxE1? M17wcHRz[W6|YXP0bZZifGmxbjDv[kBRWEGUZ3HtcYEhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJINwNXS{YX7z[oVkfGWmIIfpeIghSVB{LWDQVmUh[XRiMUCgeW0h[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5 NWfvSYlYOjN{N{O1NVk>
HEK293 cells MmjMSpVv[3Srb36gZZN{[Xl? NE\md|BC\2:waYP0JIF1KGi3bXHuJHBRSVKpYX3tZUBNSkRiZYjwdoV{e2WmIHnuJIh2dWGwIFjFT|I6OyClZXzsd{Bkd3S{YX7z[oVkfGWmIIfpeIghT0GOND3MeYMh[XO|ZYPz[YQh[XNidILhcpNkemmydHnvcoFtKGGldHn2ZZRqd25iYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvODB2IN88US=> Ml6wNlMzQDZ5OEe=
HEK293 cells MVrGeY5kfGmxbjDhd5NigQ>? Mn;VNlQhcA>? MXPUdoFve2GldHn2ZZRqd25ib3[gS2FNPCCGQlSt[pV{\WRiaIXtZY4hWFCDUnfhcY1iNUyERDDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHHmeIVzKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYmsJGVEPTB;MD6xJO69VQ>? MoHVNlMzQTR6M{C=
HEK293 cells M4ruSGZ2dmO2aX;uJIF{e2G7 NIfMVVQ1QCCqcoO= MV\B[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHPveJJidnOoZXP0[YQhf2m2aDDQVHJGgDRvVFutcJVkKGG|c3Xzd4VlKGG|IHHjeIl3[XSrb36gc4YhdHWlaX\ldoF{\SCjY4Tpeol1gSCvZXHzeZJm\CCjZoTldkA1QCCqcoOgZpkhfHKjboPhZ5RqfmG2aX;uJIF{e2G7LDDFR|UxRTR|LkexJO69VQ>? M4S3SFI{OjZ3OES0
HepG2 cells Mnu1SpVv[3Srb36gZZN{[Xl? NV7kcXR5SWexbnnzeEBi[3Srdnn0fUBifCCJQVy0MYZ2e2WmIGDQRXJo[W2vYTCoeY5sdm:5bjDvdolocW5rIHX4dJJme3OnZDDpckBpfW2jbjDI[ZBIOiClZXzsd{BjgSC2cnHud4FkfGm4YYTpc44h[XO|YYmsJGVEPTB;MD6wNUDPxE1? MXyyN|UxOjJzMh?=
HepG2 cells NV7pV49DTnWwY4Tpc44h[XO|YYm= NWXPWXd3SWexbnnzeEBi[3Srdnn0fUBifCCJQVy0MYZ2e2WmIGDQRXJo[W2vYTDNOFY{SSCvdYThcpQhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iaIXtZY4hUGWyR{KgZ4VtdHNiYomgeJJidnOjY4TpeoF1cW:wIHHzd4F6NCCHQ{WwQVAvODB{IN88US=> NF\qSWwzOzVyMkKxNi=>
L6 cells M4j0NmZ2dmO2aX;uJIF{e2G7 NWDxdYp1OjRiaILz NUH1dIxNUW6mdXP0bY9vKG:oIHfseYNwe2VidYD0ZYtmKGmwIILheEBNPiClZXzsd{BxfWy|ZXSge4l1cCCFMUSt[IVwgHliZ3z1Z49{\SCjZoTldkAzPCCqcoOgbY4heHKnc3XuZ4Uhd2ZiaX7zeYxqdixiRVO1NF01NjR7IN88US=> Ml23NlM6QTJ6NkK=
L6 cells MmfxSpVv[3Srb36gZZN{[Xl? M4LhUlE3KGi{cx?= M1GzV2lv[3KnYYPlJIlvKDJvW{PIYU1l\W:6eXfseYNwe2VidYD0ZYtmKGmwIILheEBNPiClZXzsd{Bi\nSncjCxOkBpenNiYomgd4NqdnSrbHzheIlwdiClb4XueIlv\yCjbnHsfZNqeyxiRVO1NF01NjhizszN NUTSV5JiOjR6MUO3N|g>
DU145 cells MkD2R5l1d3SxeHnjbZR6KGG|c3H5 MXy0PEBpenN? MYjDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDEWVE1PSClZXzsd{Bie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCHQ{WwQVE3KM7:TR?= NX3RcYZJOjR7OU[xOFM>
PC3 cells NXH4T|diS3m2b4TvfIlkcXS7IHHzd4F6 NGfNOmI1QCCqcoO= M1O3OmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJHBEOyClZXzsd{Bie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA1QCCqcoOgZpkhVVSWIHHzd4F6NCCHQ{WwQVIxNjNizszN M1L3WVI1QTl4MUSz
MDA-MB-231 cells NF7wcFlIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NVTqeJdUOjRiaILz NUjHbm9sT3Kxd4ToJIlvcGmkaYTpc44hd2ZiaIXtZY4hVUSDLV3CMVI{OSClZXzsd{Bi\nSncjCyOEBpenNiYomgUXRVKGG|c3H5MEBGSzVyPUWuNlMh|ryP MlL5NlUzPzh{M{[=
HEK293 cells NXnOVYNVTnWwY4Tpc44h[XO|YYm= MY\B[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTDlfJBz\XO|ZXSgbY4hUEWNMkmzJINmdGy|IHL5JIx2[2moZYLhd4UhemWyb4L0[ZIh\2WwZTDhd5NigSxiRVO1NF0xNjBzIN88US=> NXnkdJg6OjV|MEW2PFg>
HepG2 cells M1HWVWZ2dmO2aX;uJIF{e2G7 M4\iV|IxKGi{cx?= M3PnbnRz[W6|YXP0bZZifGmxbjDv[kBRWEGUIITyZY5{\mWldHXkJIlvKGi3bXHuJGhmeEd{IHPlcIx{KGGodHXyJFIxKGi{czDifUBRWEGULXz1Z4ln\XKjc3WgZZN{[XluIFXDOVA:OS54IN88US=> M{DqbVI2PDN5M{C0
HEK293 cells M{XB[mZ2dmO2aX;uJIF{e2G7 NH7xeIYzPCCqcoO= MUfUdoFve2GldHn2ZZRqd25ib3[gVHBCWmejbX3hJEh2dmuwb4fuJI9zcWerbjmg[ZhxemW|c3XkJIlvKEiHS{K5N{Bk\WyuczDpcoN2[mG2ZXSg[o9zKDJ2IHjyd{BjgSCudXPp[oVz[XOnIILldI9zfGW{IHflcoUh[XO|YYm= MlzpNlU1PDJ|MkK=
HepG2 cells NULodnlpTnWwY4Tpc44h[XO|YYm= MVPB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIFfBUFQuWFCDUnfhcY1iKGyrZ3Hu[EBjcW6maX7nJIRwdWGrbjDlfJBz\XO|ZXSgbY4hcHWvYX6gTIVxTzJiY3XscJMh[nlibIXjbYZmemG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuNFM6KM7:TR?= MlmwNlU1PjJ{OEG=
HEK293 cells Mn\MSpVv[3Srb36gZZN{[Xl? NFeye4czPCCqcoO= NWDLNGV2SWexbnnzeEBi[3Srdnn0fUBifCCvb4Xz[UBRWEGUZ3HtcYEh\XiycnXzd4VlKGmwIFjFT|I6OyClZXzsd{Bkdy2neIDy[ZN{cW6pIIfpeIghT2GuNDDy[ZBwenSncjD2[YN1d3JiYX\0[ZIhOjRiaILzJIJ6KGS3YXytcJVkcW[ncnHz[UBz\XCxcoTldkBie3OjeTygSWM2OD1yLkCzJO69VQ>? MUiyOFk2PTh6OR?=
HepG2 cells MWPGeY5kfGmxbjDhd5NigQ>? NFzqNIYzOCCqcoO= Ml;hRYdwdmm|dDDhZ5Rqfmm2eTDheEBISUx2LVTORUBjcW6maX7nJIRwdWGrbjDmeZNm\CCqdX3hckBRWEGUZ3HtcYEhdGmpYX7kJIJqdmSrbneg[I9u[WmwIHX4dJJme3OnZDDpckBpfW2jbjDI[ZBIOiClZXzsd{Bie3Onc4Pl[EBieyC{ZXPldJRweiC2cnHud4FkfGm4YYTpc44hcW6ldXLheIVlKG[xcjCyNEBpenNiYomgcJVkcW[ncnHz[UBz\XCxcoTldkBo\W6nIHHzd4F6NCCHQ{WwQVAvODRizszN NWPTVnBLOjV2OUexN|I>
HepaR cells MUTGeY5kfGmxbjDhd5NigQ>? NV3yR4hFOSCmYYm= NU[5[2tSSWexbnnzeEBi[3Srdnn0fUBifCCSUFHS[4FudWFiaX6gbJVu[W5iSHXwZXIh[2WubIOgZZN{\XO|ZXSgZZMhcW6lcnXhd4UhcW5iSF3HR3MzKGenbnWg[ZhxemW|c3nvckBifCBzIIXNJIlv[3WkYYTl[EBnd3JiMTDkZZkh[nlicYXhcpRqfGG2aY\lJHBEWiCvZYToc4QhemWuYYTpeoUhfG9idX70doVifGWmIHPvcpRzd2x? NH;SXVIzPTR7N{GzNi=>
HepaR cells MYLGeY5kfGmxbjDhd5NigQ>? MlizNUB2VQ>? M1rVflEh\GG7 NEP2NIpC\2:waYP0JIFkfGm4aYT5JIF1KFCSQWLnZY1u[SCrbjDoeY1idiCKZYDhVkBk\WyuczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCDTlfQWGw1KGenbnWg[ZhxemW|c3nvckBifCBzIIXNJIlv[3WkYYTl[EBnd3JiMTDkZZkh[nlicYXhcpRqfGG2aY\lJHBEWiCvZYToc4QhemWuYYTpeoUhfG9idX70doVifGWmIHPvcpRzd2x? NFrhdoMzPTR7N{GzNi=>
HepaR cells M1rWTWZ2dmO2aX;uJIF{e2G7 M{X3b|EhfU1? NYWyPVV{OSCmYYm= M3XVb2Fod26rc4SgZYN1cX[rdImgZZQhWFCDUnfhcY1iKGmwIHj1cYFvKEincHHSJINmdGy|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKE[DQmCxJIdmdmViZYjwdoV{e2mxbjDheEAyKHWPIHnuZ5Vj[XSnZDDmc5IhOSCmYYmgZpkheXWjboTpeIF1cX[nIGDDVkBu\XSqb3SgdoVt[XSrdnWgeI8hfW62cnXheIVlKGOxboTyc4w> MlrKNlU1QTdzM{K=
HEK293 cells NWX5RXF4TnWwY4Tpc44h[XO|YYm= MYqxNEDPxE1? NH34WI0zPCCqcoO= Mk\yWJJidnOjY4TpeoF1cW:wIH;mJHBRSVJvZ3HtcYEhMHWwa37ve44hd3KrZ3nuLUBmgHC{ZYPz[YQhcW5iSFXLNlk{KGOnbHzzJIF1KDFyIIXNJIFnfGW{IEK0JIhzeyCkeTDseYNq\mW{YYPlJJJmeG:{dHXyJIdmdmViYYPzZZk> NHPyV4ozPDh7MEC5NC=>
C2C12 cells M2DsSGZ2dmO2aX;uJIF{e2G7 NHXQeHU{OCEQvF2= Ml[4NkBp NYD6cFBRUW6mdXP0bY9vKG:oIEKt[IVwgHlvW{PIYU1odHWlb4PlJJVxfGGtZTDpckBud3W|ZTDDNmMyOiClZXzsd{BifCB|MDD1UUBi\nSncjCyJIhzeyCkeTDsbZF2cWRic3PpcpRqdGyjdHnvckBkd3WwdHnu[{BidmGueYPpdy=> MYqyOVg{PTV|Nx?=
MCF7 cells MlGxSpVv[3Srb36gZZN{[Xl? NEPTPHkyPiCq MYDB[49vcXO2IHHjeIl3cXS7IHH0JIh2dWGwIGDQRXJo[W2vYTD0doFve2[nY4Tl[EBqdiCqdX3hckBOS0Z5IHPlcIx{KGGodHXyJFE3KGi{czDifUBtfWOrZnXyZZNmKHKncH;yeIVzKGenbnWgZZN{[XluIFXDOVA:OC5yOEeg{txO MUiyOlIzPjR7MB?=
HEK293 cells NU[0T|c4TnWwY4Tpc44h[XO|YYm= NUXmXpRrOTBizszN M1\lfVI1KGh? MVjB[49vcXO2IHHjeIl3cXS7IHH0JHBRSVKpYX3tZUApfW6tbn;3ckBwemmpaX6pJIV5eHKnc4Pl[EBqdiCKRVuyPVMh[2WubIOgZZN{\XO|ZXSgZZMhemWlZYD0c5IhfHKjboPhZ5RqfmG2aX;uJIF1KDFyIIXNJIlv[3WkYYTl[EBnd3JiMkSgbJJ{KGK7IHz1Z4ln\XKjc3WgdoVxd3K2ZYKg[4Vv\SCjc4PhfS=> MlHZNlY{QDR{OE[=

... Click to View More Cell Line Experimental Data

Protocol

References

Solubility (25°C)

In vitro DMSO 35 mg/mL (198.67 mM)
Ethanol 35 mg/mL (198.67 mM)
Water Insoluble

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 176.17
Formula

C10H8O3

CAS No. 90-33-5
Storage powder
in solvent
Synonyms N/A

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT00225537 Unknown status Chronic Hepatitis C|Chronic Hepatitis B MTmedical Institute of Health|The University of Texas Health Science Center at San Antonio|BioMonde Preparations Limited September 2005 Phase 2
NCT00225537 Unknown status Chronic Hepatitis C|Chronic Hepatitis B MTmedical Institute of Health|The University of Texas Health Science Center at San Antonio|BioMonde Preparations Limited September 2005 Phase 2

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Related Others Products0

Tags: buy 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) supplier | purchase 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) cost | 4-Methylumbelliferone (4-MU) manufacturer | order 4-Methylumbelliferone (4-MU) | 4-Methylumbelliferone (4-MU) distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID